Table 3 Characteristics and results of plasma and CSF analysis of sCAA patients and controls

Age (years)

72 ± 6

72 ± 6

0.94^a

–

Sex, F/M (n)

27/34

21/21

0.56^b

–

MOCA

26 [23–27]; n = 26

N.A.

–

–

Plasma

 Aβ38 (pg/ml)

19.5 [15.8–22.8]

17.1 [13.2–20.6]

0.077^a/0.092^§

1.92 (-0.32–4.17)

 Aβ40 (pg/ml)

169 [153–195]

155 [137–192]

0.14^a/0.64^§

3.97 (− 12.71–20.64)

 Aβ42 (pg/ml)

31.9 ± 8.13

32.1 ± 6.03

0.74^a/0.68^§

0.58 (− 2.16–3.33)

CSF

 Aβ38 (pg/ml)

2174 ± 850; n = 16

N.A.

–

–

 Aβ40 (ng/ml)

6.36 ± 2.92; n = 30

N.A

–

–

 Aβ42 (pg/ml)

336 [165–400]; n = 30

N.A

–

–